Literature DB >> 14726641

Ablation of symptomatic cysts using absolute ethanol in 11 patients with autosomal-dominant polycystic kidney disease.

Young Rae Lee1, Kyu-Beck Lee.   

Abstract

OBJECTIVE: To evaluate the effects of cyst ablation with absolute ethanol in autosomal-dominant polycystic kidney disease (ADPKD) patients with symptomatic cysts.
MATERIALS AND METHODS: Using absolute ethanol, cyst ablation was performed in 11 patients with documented ADPKD who suffered cyst pain refractory to medical treatment. An ethanol solution was instilled into the largest symptomatic cysts through a catheter. We assessed the therapeutic efficacy of the procedure by tracking subjective pain relief during a 3 to 24-month follow-up period after ablation.
RESULTS: At follow-up, we found that the duration of subjective pain relief was 12 to 24 months in seven patients, 4 to 11 months in one, and less than 3 months in three.
CONCLUSION: Selective ablation of a symptomatic cyst may be a valid option in managing chronic pain caused by one or a few large cysts in ADPKD patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14726641      PMCID: PMC2698102          DOI: 10.3348/kjr.2003.4.4.239

Source DB:  PubMed          Journal:  Korean J Radiol        ISSN: 1229-6929            Impact factor:   3.500


  20 in total

1.  Treatment of simple renal cysts by percutaneous drainage with three repeated alcohol injection.

Authors:  D Fontana; F Porpiglia; I Morra; P Destefanis
Journal:  Urology       Date:  1999-05       Impact factor: 2.649

2.  Sclerotherapy of a giant renal cyst with povidone-iodine.

Authors:  Michael Peyromaure; Bernard Debré; Thierry A Flam
Journal:  J Urol       Date:  2002-12       Impact factor: 7.450

3.  Acetic acid as a sclerosing agent for renal cysts: comparison with ethanol in follow-up results.

Authors:  T S Seo; J H Oh; Y Yoon; J W Lim; S J Park; S G Chang; Y H Jeon
Journal:  Cardiovasc Intervent Radiol       Date:  2000 May-Jun       Impact factor: 2.740

4.  Laparoscopic cyst marsupialization in patients with autosomal dominant polycystic kidney disease.

Authors:  M D Dunn; A J Portis; C Naughton; A Shalhav; E M McDougall; R V Clayman
Journal:  J Urol       Date:  2001-06       Impact factor: 7.450

Review 5.  Pathophysiology and clinical management of polycystic kidney disease in women.

Authors:  P D Wilson; L Guay-Woodford
Journal:  Semin Nephrol       Date:  1999-03       Impact factor: 5.299

6.  Cyst sclerotherapy with minocycline hydrochloride in patients with autosomal dominant polycystic kidney disease.

Authors:  J Uemasu; M Fujihara; C Munemura; E Nakamura; H Kawasaki
Journal:  Nephrol Dial Transplant       Date:  1996-05       Impact factor: 5.992

7.  Aspiration and sclerotherapy of symptomatic simple renal cysts: value of two injections of a sclerosing agent.

Authors:  R M Hanna; M H Dahniya
Journal:  AJR Am J Roentgenol       Date:  1996-09       Impact factor: 3.959

8.  Percutaneous sclerotherapy of a giant benign renal cyst with alcohol.

Authors:  F B Bozkurt; F Boyvat; I Tekin; C Aytekin; M Coskun; H Ozkardes
Journal:  Eur J Radiol       Date:  2001-10       Impact factor: 3.528

9.  Comparison of single and multiple sessions of percutaneous sclerotherapy for simple renal cyst.

Authors:  B H Chung; J H Kim; C H Hong; S C Yang; M S Lee
Journal:  BJU Int       Date:  2000-04       Impact factor: 5.588

Review 10.  Pain management in polycystic kidney disease.

Authors:  Z H Bajwa; S Gupta; C A Warfield; T I Steinman
Journal:  Kidney Int       Date:  2001-11       Impact factor: 10.612

View more
  7 in total

1.  Long-term functional results of aspiration and sclerotherapy with ethanol in patients with autosomal dominant polycystic kidney disease: a non-randomized pilot clinical study.

Authors:  Eyüp Veli Küçük; Ahmet Tahra; Ahmet Bindayi; Ferhat Yakup Suçeken; Fikret Fatih Önol; Uğur Boylu
Journal:  Int Urol Nephrol       Date:  2016-01-12       Impact factor: 2.370

Review 2.  Evaluation and management of pain in autosomal dominant polycystic kidney disease.

Authors:  Marie C Hogan; Suzanne M Norby
Journal:  Adv Chronic Kidney Dis       Date:  2010-05       Impact factor: 3.620

3.  Cyst ablation using a mixture of N-butyl cyanoacrylate and iodized oil in patients with autosomal dominant polycystic kidney disease: the long-term results.

Authors:  See Hyung Kim; Seung Hyup Kim; Jeong Yeon Cho
Journal:  Korean J Radiol       Date:  2009-06-25       Impact factor: 3.500

Review 4.  A stepwise approach for effective management of chronic pain in autosomal-dominant polycystic kidney disease.

Authors:  Niek F Casteleijn; Folkert W Visser; Joost P H Drenth; Tom J G Gevers; Gerbrand J Groen; Marie C Hogan; Ron T Gansevoort
Journal:  Nephrol Dial Transplant       Date:  2014-09       Impact factor: 5.992

5.  Comparison of CT-guided sclerotherapy with using 95% ethanol and 20% hypertonic saline for managing simple renal cyst.

Authors:  Hulusi Egilmez; Vedat Gok; Ibrahim Oztoprak; Mehmet Atalar; Ali Cetin; Mubeccel Arslan; Yener Gultekin; Orhan Solak
Journal:  Korean J Radiol       Date:  2007 Nov-Dec       Impact factor: 3.500

6.  Aspiration-sclerotherapy results in effective control of liver volume in patients with liver cysts.

Authors:  Loes van Keimpema; Daan B de Koning; Simon P Strijk; Joost P H Drenth
Journal:  Dig Dis Sci       Date:  2008-02-26       Impact factor: 3.199

7.  Foam Sclerotherapy for Cyst Volume Reduction in Autosomal Dominant Polycystic Kidney Disease: A Prospective Cohort Study.

Authors:  Ioan-Andrei Iliuta; Beili Shi; Marina Pourafkari; Pedram Akbari; Giancarlo Bruni; Ralph Hsiao; Steffan F Stella; Korosh Khalili; Eran Shlomovitz; York Pei
Journal:  Kidney Med       Date:  2019-10-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.